[GAVI] Denmark and Geneva, Switzerland -- The advance purchase agreement (APA) will be funded by Gavi's First Response Fund, a mechanism created after the COVID-19 pandemic to ensure rapid access to scarce vaccine supplies in future health emergencies. Availability of all 500,000 doses has been secured for 2024.